Today

Agents

Chat

Arena

Discover

More

App

H.C. Wainwright cuts Akebia Therapeutics target price to $4 from $6

AKBA•2026-11-06

H.C. Wainwright cut its target price for Akebia Therapeutics to $4 from $6.

Related News

D

Higher costs offset Domino's growth for India's Jubilant FoodWorks; profit flat

DPZ•2026-11-06

Silynxcom CEO Nir Klein reports $19,707.24 purchase of common shares

SYNX•2026-11-06

Cloudflare: Needham cuts target price to $365 from $380

NET•2026-11-06

Passage Bio holds special stockholder meeting

PASG•2026-11-06

As tech swoon roils market, US inflation data on tap

SPY•2026-11-06

H.C. Wainwright cuts Akebia Therapeutics target price to $4 from $6 - AKBA News | Rallies